United States· US:84571-140_4525b96b-5ab9-b8fd-e063-6294a90aa699
ZIMHI
A medicinal product containing naloxone hydrochloride, registered in United States by ZMI Pharma Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NALOXONE HYDROCHLORIDE
- Manufacturer
- ZMI Pharma Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1184571-140-02
- ndc1184571-140-11
- ndc1184571140022 CASE in 1 CARTON (84571-140-02) / 1 SYRINGE in 1 CASE / .5 mL in 1 SYRINGE
- ndc1184571140111 CASE in 1 CARTON (84571-140-11) / 1 SYRINGE in 1 CASE / .5 mL in 1 SYRINGE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Naloxone hydrochloride in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomNaloxone 1.26mg/0.1ml nasal spray unit doseA A H Pharmaceuticals Ltd
- GermanyNaloxon AccordAccord Healthcare B.V.
- BelgiumNaloxon B. Braun 0.4 mg/mlB. Braun Melsungen
- CanadaINJECTABLE NALOXONE HYDROCHLORIDEOMEGA LABORATORIES LIMITED
- PolandNaloxone AccordAccord Healthcare Polska Sp. z o.o.
- FinlandNalofarmOrifarm Oy
- SwedenNaloxon actrevo 3,6 mg Nässpray, lösning i endosbehållareActrevo GmbH
- NetherlandsNaloxon HCl Accord 0,4 mg/ml, oplossing voor injectie / infusie in een voorgevulde spuitAccord Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Forvel, Naloxon Accord
- Belgium · Naloxon B. Braun
- Bulgaria · Форвел
- Cyprus · Codaxol, Forvel
- Czechia · Forvel, Naloxone Polpharma
- Germany · Naloxon Accord, Naloxon B. Braun
- Denmark · Forvel, Naloxon B. Braun
- Estonia · Forvel, Ventizolve
- Spain · Fomed, Naloxona B. Braun
- Finland · Naloxone Accord, Nexodal
- France · Naloxone Accord, Naloxone Adapt Pharma
- United Kingdom (Northern Ireland) · Naloxone Accord-Uk, Naloxone B. Braun Melsungen
- Greece · Forvel, Νaloxon B.Braun
- Croatia · Forvel
- Hungary · Nexodal
- Ireland · Naloxone Hydrochloride Accord, Naloxone Hydrochloride Mercury Pharmaceuticals (Ireland)
- Iceland · Naloxon B. Braun, Nyxoid
- Italy · Naloxone Accord, Naloxone Adapt
- Liechtenstein · Nyxoid
- Lithuania · Forvel
- Luxembourg · Naloxon B. Braun
- Latvia · Forvel
- Malta · Forvel
- Netherlands · Naloxon Hci B. Braun, Naloxon Hcl Accord
- Norway · Naloxon B. Braun, Naloxon Hameln
- Poland · Naloxonum Hydrochloricum Wzf
- Portugal · Forvel, Naloxona Accord
- Romania · Forvel
- Sweden · Naloxon Actrevo, Naloxon Hameln
- Slovenia · Nexodal
- Slovakia · Naloxone Polpharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/da77c02f-093d-47c8-8d25-e3edeeae2137 GET /v1/drugs/da77c02f-093d-47c8-8d25-e3edeeae2137?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAMUSCULAR; SUBCUTANEOUS",
"source": "ndc",
"strength": "5",
"substance": "NALOXONE HYDROCHLORIDE",
"productndc": "84571-140",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/.5mL",
"application_number": "NDA212854",
"marketing_category": "NDA"
}See everything about naloxone hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.